Invention Grant
- Patent Title: Method of inhibiting mutant C-KIT
-
Application No.: US15862011Application Date: 2018-01-04
-
Publication No.: US10251877B2Publication Date: 2019-04-09
- Inventor: Vinay K. Jain
- Applicant: Arog Pharmaceuticals, Inc.
- Applicant Address: US TX Dallas
- Assignee: Arog Pharmaceuticals, Inc.
- Current Assignee: Arog Pharmaceuticals, Inc.
- Current Assignee Address: US TX Dallas
- Agency: Chalker Flores, LLP
- Agent Edwin S. Flores; Daniel J. Chalker
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61K31/4709 ; A61K45/06
Abstract:
The present invention includes a method of reducing or inhibiting the kinase activity of C-KIT mutant tyrosine kinase activity in a cell or a subject, and the use of such compound for treating mutant C-KIT driven cell proliferative disorder(s) in a subject related to using a compound of the present invention: or pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20180125839A1 METHOD OF INHIBITING MUTANT C-KIT Public/Granted day:2018-05-10
Information query
